Women who take estrogen-only hormone-replacement therapy to relieve menopausal symptoms might also be reducing their risk for a common form of the eye disease glaucoma, according to new research. Louis Pasquale, associate professor of ophthalmology at Massachusetts Eye and Ear Infirmary, is an author on the paper. Angela Turalba, instructor in ophthalmology at Massachusetts Eye and Ear Infirmary, is quoted.
